Related Experiment Video
Updated: Jun 4, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Extraluminal factors contributing to inflammatory bowel disease
Arvind Batra1, Thorsten Stroh, Britta Siegmund
1Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Medical Department I, Gastroenterology/Rheumatology/Infectious Diseases, Hindenburgdamm 30, 12200 Berlin, Germany.
Inflammatory bowel disease (IBD) involves genetic and environmental factors disrupting the gut immune system. This review highlights the roles of mesenteric fat, lymphatics, and microvasculature in IBD pathogenesis, offering new therapeutic targets.
Area of Science:
- Gastroenterology
- Immunology
- Pathogenesis of Inflammatory Bowel Disease (IBD)
Background:
- IBD pathogenesis is multifactorial, involving genetic predisposition and environmental triggers.
- Current research often focuses on the intestinal wall's immune response.
- Dysregulation of the mucosal immune system is central to IBD development.
Purpose of the Study:
- To review the contribution of extraluminal structures to IBD pathogenesis.
- To emphasize the roles of mesenteric fat tissue, lymphatics, and microvasculature.
- To identify novel therapeutic targets by broadening the scope beyond the intestinal wall.
Main Methods:
- Literature review focusing on extraluminal contributions to IBD.
- Synthesis of existing research on mesenteric fat, lymphatics, and microvasculature in IBD.
- Analysis of how these structures influence the mucosal immune system.
Main Results:
- Mesenteric fat tissue plays a significant role in modulating intestinal inflammation.
- Lymphatic vessels are implicated in immune cell trafficking and inflammatory responses in IBD.
- The intestinal microvasculature is crucial for inflammatory cell recruitment and tissue damage.
Conclusions:
- Extraluminal structures, including mesenteric fat, lymphatics, and microvasculature, are critical in IBD pathogenesis.
- Understanding these extraluminal contributions is essential for a comprehensive view of IBD.
- Targeting these structures may offer new therapeutic strategies for IBD management.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
